Intratympanic gentamicin compared with placebo for Ménière's disease
INTRODUCTION Ménière's disease is a multifactorial disorder affecting the inner ear, characterized by episodes of spontaneous and recurrent vertigo, fluctuating hearing loss and tinnitus. Intratympanic gentamicin therapy has been used to reduce the intensity and frequency of attacks in intract...
Main Authors: | Fernanda de Amesti, Maria Jesus Santander, Matias Winter |
---|---|
Format: | Article |
Language: | English |
Published: |
Medwave Estudios Limitada
2022-02-01
|
Series: | Medwave |
Subjects: | |
Online Access: | https://www.medwave.cl/link.cgi/Medwave/PuestaDia/ResEpis/8696.act |
Similar Items
-
Positive pressure therapy for Ménière’s disease
by: Jorge Holmberg, et al.
Published: (2019-04-01) -
Intratympanic Gentamicin for Intractable Ménière's Disease – A Review and Analysis of Audiovestibular Impact
by: Sertaç Yetişer
Published: (2018-04-01) -
A Case of Binocular Vertical Diplopia after Intratympanic Gentamicin Therapy
by: Giacomo Cioffi, et al.
Published: (2019-07-01) -
Use of Skull Vibration-Induced Nystagmus in the Follow-up of Patients With Ménière Disease Treated With Intratympanic Gentamicin
by: Susana Marcos Alonso, et al.
Published: (2023-08-01) -
Effects of an Intratympanic Injection of Dexamethasone Combined with Gentamicin on the Expression Level of Serum P0 Protein Antibodies in Patients with Meniere’s Disease
by: Yang Geng, et al.
Published: (2020-11-01)